“…During the last decades the anticancer activity of organotin compounds (OTCs) has been well studied [ 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 ]. Therefore, the investigation of new OTCs of low toxicity and improved anticancer activity are known to induce apoptosis in several cancer cell lines [ 17 , 18 , 19 ].…”